// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Primary immune thrombocytopenia in Great Britain: epidemiology and service utilisation

U Doobaree - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Impact of next generation sequencing on diagnosis of rare inherited anaemia

F Smith - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Successful pregnancy outcome in a patient with homozygosity for Hb Luton and alpha thalassaemia

F Sillito - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Aspirin

Prevalence of opioid‐associated endocrinopathy in sickle cell disease

G Adams - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

Morphine

The disappearing haemoglobinopathy trait

K Leighton - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Propylthiouracil

The National Haemoglobinopathy Registry

B Ahsan - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Hydroxycarbamide

Successful full term pregnancy and normal delivery with massive splenomegaly caused by red cell membranopathy due to a previously undescribed mutation in alpha‐spectrin SPTA1 gene

H Sinclair - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Low fidelity simulation for clinical protocol training in sickle cell disease

L Ghani - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

Naloxone

An interesting case of haemoglobinopathy disgnosed during antenatal screening

J Tam - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

Unmet psychological need/support in patients with sickle cell disease

G Bridges - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

A retrospective, observational study of children attending in two major thalassemia centres in Dhaka, Bangladesh in 2016. A low income countries perspective

A Islam - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Sickle cell and mental health

K Romain - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Glomerular hyperfiltration in children with sickle cell anaemia is associated with increased red cell cation channel activity

J Brewin - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Hydroxyurea

Improving time to set up patient‐controlled analgesia for patients with sickle cell disease admitted with a painful crisis through the emergency department

L Aiken - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Fat embolism syndrome in a patient with sickle cell haemoglobin C disease

L Linpower - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Double heterozygocity for HbC and beta thalassaemia dominant: a rare cause of thalassaemia intermedia

A Agapidou - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Hydroxycarbamide

Complete blood count in high altitude area 2500 meters above sea level among Saudi adults: a cross sectional hospital based study from October 2016 to December 2016

A Gaffer - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Development and evaluation of a specialised pain service for sickle cell disease associated pain

J Love - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

Methadone hydrochloride

An investigational RNAi therapeutic (ALN‐CC5) targeting complement C5 for treatment of PNH and complement‐mediated diseases: exploratory analysis of interim phase 1/2 study results supports reduced eculizumab dosing in patients with PNH

A Hill - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Cyclosporine A

Single centre audit of testicular examination practice in children with acute lymphoblastic leukaemia

I Wardach - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved